PRELUDE THERAPEUTICS INC

Ticker: PRLD CUSIP: 74065P101 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 75,161 Value ($000) $0 Avg Close $1.00 Range $0.75 - $1.91
Q2 2025
Shares 71,378 Value ($000) $0 Avg Close $0.87 Range $0.61 - $1.25
Q3 2023
Shares 70,583 Value ($000) $0 Avg Close $3.75 Range $2.65 - $5.01
Q2 2023
Shares 72,834 Value ($000) $0 Avg Close $5.98 Range $4.25 - $8.56
Q1 2023
Shares 47,614 Value ($000) $0 Avg Close $6.10 Range $4.42 - $7.65
Q4 2022
Shares 47,801 Value ($000) $0 Avg Close $6.41 Range $4.49 - $8.66
Q3 2022
Shares 54,173 Value ($000) $358 Avg Close $6.74 Range $4.77 - $8.90
Q2 2022
Shares 36,626 Value ($000) $191 Avg Close $5.09 Range $3.87 - $7.96
Q1 2022
Shares 23,201 Value ($000) $160 Avg Close $9.15 Range $6.76 - $13.40